Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q30201: Variant p.Val295Ala

Hereditary hemochromatosis protein
Gene: HFE
Feedback?
Variant information Variant position: help 295 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Valine (V) to Alanine (A) at position 295 (V295A, p.Val295Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (V) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In HFE1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 295 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 348 The length of the canonical sequence.
Location on the sequence: help GEEQRYTCQVEHPGLDQPLI V IWEPSPSGTLVIGVISGIAV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GEEQRYTCQVEHPGLDQPLIVIWEPSPSGTLVIGVISGIAV

Chimpanzee                    GEEQRYTCQVEHPGLDQPLIVIWEPSPSGTLVIGVISGIAV

Mouse                         GDETRFTCQVEHPGLDQPLTASWEPLQSQAMIIGIISGVTV

Rat                           GEETRFSCQVEHPGLDQPLTATWEPSRSQDMIIGIISGITI

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 23 – 348 Hereditary hemochromatosis protein
Topological domain 23 – 306 Extracellular
Domain 207 – 298 Ig-like C1-type
Region 206 – 297 Alpha-3
Alternative sequence 27 – 298 Missing. In isoform 11.
Alternative sequence 162 – 348 Missing. In isoform 9.
Alternative sequence 277 – 348 Missing. In isoform 8.
Beta strand 293 – 296



Literature citations
Comprehensive hereditary hemochromatosis genotyping.
Jones D.C.; Young N.T.; Pigott C.; Fuggle S.V.; Barnardo M.C.N.M.; Marshall S.E.; Bunce M.;
Tissue Antigens 60:481-488(2002)
Cited for: VARIANTS HFE1 CYS-65; TYR-282 AND ALA-295; Gene symbol: HFE. Disease: haemochromatosis.
Bento M.C.; Ribeiro M.L.; Relvas L.;
Hum. Genet. 114:405-405(2004)
Cited for: VARIANT HFE1 ALA-295;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.